RETRACTION: Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis

RETRACTION: Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis

Saved in:

Bibliographic Details
Main Author:	Mediators of Inflammation
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/mi/9829464
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression of concern: “Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis” [Experimental and Molecular Pathology 97 (2014) 470–476]
Published: (2025-06-01)

MSCs engineered with secreted Klotho alleviate blood–brain barrier disruption and reduce neuroinflammation more effectively than MSCs in experimental autoimmune encephalomyelitis
by: Narges Maleki, et al.
Published: (2025-07-01)

Pharmacological Inhibition of Microglial Proliferation Supports Blood–Brain Barrier Integrity in Experimental Autoimmune Encephalomyelitis
by: Nozha Borjini, et al.
Published: (2025-03-01)

Expression of concern: “Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors” [Experimental and Molecular Pathology 99 (2015) 212–219]
Published: (2025-06-01)

Retracted: Protective Effects of Pretreatment with Oleanolic Acid in Rats in the Acute Phase of Hepatic Ischemia-Reperfusion Injury: Role of the PI3K/Akt Pathway
by: Mediators of Inflammation
Published: (2022-01-01)

Retracted: Neuropilin-1highCD4+CD25+ Regulatory T Cells Exhibit Primary Negative Immunoregulation in Sepsis
by: Mediators of Inflammation
Published: (2020-01-01)

Retracted: Efficacy of Human-Recombinant Epidermal Growth Factor Combined with Povidone-Iodine for Pressure Ulcers and Its Influence on Inflammatory Cytokines
by: Mediators of Inflammation
Published: (2023-01-01)

RETRACTION: lncRNA SNHG14 Plays a Role in Sepsis-Induced Acute Kidney Injury by Regulating miR-93
by: Mediators of Inflammation
Published: (2025-01-01)

Retracted: VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway
by: Mediators of Inflammation
Published: (2022-01-01)

Behavioral investigation of mice with experimental autoimmune encephalomyelitis
by: David Henrique Rodrigues, et al.
Published: (2011-12-01)

Therapeutic potential of agmatine in the experimental autoimmune encephalomyelitis
by: Stevanović Ivana, et al.
Published: (2021-01-01)

Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomyelitis
by: Dušan Radojević, et al.
Published: (2022-12-01)

Identification of the microglia-associated signature in experimental autoimmune encephalomyelitis
by: Yan Wu, et al.
Published: (2025-06-01)

R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
by: Katja Schmitz, et al.
Published: (2014-09-01)

Expression of Concern on “IκB Kinase Inhibitor VII Modulates Sepsis-Induced Excessive Inflammation and Cardiac Dysfunction in 5/6 Nephrectomized Mice”
by: Mediators of Inflammation
Published: (2023-01-01)

Experimental autoimmune encephalomyelitis causes skeletal muscle dysfunction in mice
by: Julian Boesch, et al.
Published: (2025-04-01)

Therapeutic Potential of Pien Tze Huang on Experimental Autoimmune Encephalomyelitis Rat
by: Xuemei Qiu, et al.
Published: (2018-01-01)

Role of autoreactive Tc17 cells in the pathogenesis of experimental autoimmune encephalomyelitis
by: Yong Peng, et al.
Published: (2024-03-01)

BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis.
by: Xiaohui Zhou, et al.
Published: (2011-01-01)

Pidotimod alleviated experimental autoimmune encephalomyelitis by regulating the balance of splenic lymphocytes
by: Yanping Wang, et al.
Published: (2025-07-01)

Theta burst stimulation promotes nestin expression in experimental autoimmune encephalomyelitis
by: Ninković Milica B., et al.
Published: (2024-01-01)

Mechanical hypernociception in experimental autoimmune encephalomyelitis Hipernocicepção mecânica em encefalomielite autoimune experimental
by: David Henrique Rodrigues, et al.
Published: (2009-03-01)

NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis
by: Si-Ting Wu, et al.
Published: (2025-06-01)

Therapeutics Potential of Cronassial in Experimental Autoimmune Encephalomyelitis: Insights Into Glycosphingolipids and Humoral Immunity
by: Gayane Ghazaryan, et al.
Published: (2025-01-01)

Essential role of NK cells in IgG therapy for experimental autoimmune encephalomyelitis.
by: Wai Po Chong, et al.
Published: (2013-01-01)

Anti‐Inflammatory Macrophage‐Derived Exosomes Modified With Self‐Antigen Peptides for Treatment of Experimental Autoimmune Encephalomyelitis
by: Qiaoyun Li, et al.
Published: (2025-04-01)

The Potential of Matrine in the Treatment of Breast Cancer: A Review
by: Yumin Yang, et al.
Published: (2025-05-01)

Seronegative Autoimmune Encephalomyelitis with Area Postrema Symptoms
by: David Andrew Prentice, et al.
Published: (2025-03-01)

Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs
by: Yuhong Yang, et al.
Published: (2010-01-01)

Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives
by: Fengna Chu, et al.
Published: (2018-01-01)

Irisin restrains neuroinflammation in mouse experimental autoimmune encephalomyelitis via regulating microglia activation
by: Qiu-Xia Zhang, et al.
Published: (2025-04-01)

The Immune-Modulatory Role of Apolipoprotein E with Emphasis on Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
by: Hong-Liang Zhang, et al.
Published: (2010-01-01)

Role of Oxidative Stress in Blood–Brain Barrier Disruption and Neurodegenerative Diseases
by: Sehwan Kim, et al.
Published: (2024-11-01)

Brain Ischemia in Alzheimer’s Disease May Partly Counteract the Disruption of the Blood–Brain Barrier
by: Grant A. Bateman, et al.
Published: (2025-03-01)

Dynamic Analysis of the Blood-Brain Barrier Disruption in Experimental Stroke Using Time Domain in Vivo Fluorescence Imaging
by: Abedelnasser Abulrob, et al.
Published: (2008-11-01)

Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
by: Sungmoo Hong, et al.
Published: (2024-12-01)

Demyelination and neurodegeneration early in experimental autoimmune encephalomyelitis contribute to functional deficits in the anterior visual pathway
by: Maria T. Sekyi, et al.
Published: (2024-10-01)

Brd4 expression in CD4 T cells and in microglia promotes neuroinflammation in experimental autoimmune encephalomyelitis
by: Anup Dey, et al.
Published: (2025-06-01)

Cronassial Ameliorates Autoimmune Encephalomyelitis by Inhibiting Lipid Oxidation and Carbonyl Stress in the Brain and Spinal Cord of Rats
by: Gayane Ghazaryan, et al.
Published: (2023-01-01)

BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental Autoimmune Encephalomyelitis
by: Sofia Fernanda Gonçalves Zorzella-Pezavento, et al.
Published: (2013-01-01)